Engineering company Neste Jacobs
Technology and engineering company Neste Jacobs, which is 60%-owned by Neste Oil, continued to develop and grow its operations in selected areas during 2011. A presence was established in the Middle East with the opening of an office in Abu Dhabi. This will offer a range of services to oil, gas, and petrochemical companies across the Middle East and support local customers in work on new projects and enhancing the efficiency of existing plants. Neste Jacobs also succeeded in winning new customers in the Nordic region, the Baltic countries, Central Europe, and Russia.
Neste Jacobs extended its activities in the biotechnology field with the signing of a major agreement with GE Healthcare. This eight-year global agreement covers the marketing, sales, and execution of blood plasma fractionation plants, and will make the two companies a leading player in projects of this type. The agreement will also benefit the long-term development of Neste Jacobs’s business and expertise in the biotechnology area.
Neste Jacobs plays an important role in helping drive Neste Oil’s strategy in the technology area. Neste Jacob’s approx. 700 engineering professionals and its long experience in oil, gas, and petrochemicals make a key contribution to scaling up Neste Oil’s Research and Technology initiatives, in investment projects, and in supporting plant operations.
Neste Jacobs extended its activities in the biotechnology field with the signing of a major agreement with GE Healthcare. This eight-year global agreement covers the marketing, sales, and execution of blood plasma fractionation plants.